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The first line of evidence came from the studies of Cameron and co-workers (3, 4, 5, 6) on the beneficial effects of yeast RNA tablets and of intravenous infusions of purified yeast RNA on senile patients with impaired memoiy function. Animal studies were later ini tiated by Cook et al. (7) , which showed that rats injected with 160 mg/kg yeast RNA learned the simple conditioned avoidance task of climbing a pole to avoid electric shock more quickly and extinguished this response more slowly in the absence of shock than did saline injected control rats. Other animal studies showed that rats injected with yeast RNA learned to run to one side of a T-maze in significantly fewer trials than did controls (18) and that RNA increased the rate of bar-pressing on a variable interval schedule and also ac celerated formation of a conditioned emotional response (28) .
The second line of thought concern ing the relation between RNA and me mory is based on the observation of Hyden (21) that rats Which had learned a balancing task showed an increased concentration of RNA and an altered RNA base ratio in their Deiters' nerve cells. These observations led to the theory that RNA could be a suitable molecule to encode memory information in the brain, in the same manner that DNA encodes genetic information in the sequential arrangement of its four bases. Thus, RNA has been described as the 'memory molecule' of the brain (17) .
The questions which we will now ask are: Can these two lines of approach toward an RNA theory of memory be drawn together? Is the evidence for the beneficial effects of yeast RNA on pa tients and on experimental animals dir ectly related to RNA coding within the brain?
The critical experiment which would unify these two ideas would be the demonstration that injected yeast RNA is able to, 1) enter the brain as a whole molecule or as a precursor and contribute to the RNA pool there or, 2) that it could stimulate the synthesis of RNA in the brain by acting upon another organ which influences brain metabolism.
These questions of the fate of injected yeast RNA have been investigated by several workers using radioactive yeast RNA labelled in different manners and analyzed by various techniques.
In the first such study (25) , N 15 label led yeast RNA was fed to rats over a three-day period and their tissues exam ined on the fourth day. The greater part of the label was recovered in allantoin, urea and ammonia. In humans, who lack the enzyme uricase, this would appear as the uric acid fraction.
Using tracer methodology Sved (29) investigated the fate of uniformly label led C" yeast RNA injected intravenously in mice. He reports that much of the administered radioactivity was found in the C0 2 exhaled within five hours, and that the rest was distributed primarily in the free nucleotides and carbohy drates. The labelled ribose portion of the RNA would account for the labelled CO a and carbohydrates. Sved (29) reports that there is a small amount of uptake into the nucleic acids of brain, lung, skeletal muscles, heart, kidney, liver and spleen, and emphasizes that there is a rapid breakdown of RNA to free bases and ribose.
The fate of exogenous yeast RNA injected into mice has also been exam ined by means of radioautography in this laboratory (14) . Mice were sacri ficed four hours after intravenous injec tion of 12 ,«c of CC, "-RNA. Grain •counts over tissue sections showed that the RNA bases were incorporated into intestine, liver, kidney, pancreas and spleen, but not into brain or muscle tissue. Evidence obtained from control slides extracted with ribonuclease and desbxyribonuclease showed that the RNA bases are incorporated primarily into DNA in rapidly dividing cells such as those of the intestinal crypts, but are used more for RNA synthesis in actively metabolizing cells of liver, kidney and pancreas. With special reference to the brain, uptake of radioactive material was observed in the choroid plexus and ependyma, but not in neural tissue. The small amount of radioactivity reported in the brain nucleic acids by Sved (29) could be attributed to this incorporation of labelled material into the choroid plexus and ependyma.
Eist and Seal (13) report that C'-RNA can pass neither the blood-CSF barrier nor the blood-brain barrier. Using tracer methodology, they examined CSF and brain homogenates of rabbits injected with 5 /ne C"-RNA. No radioactivity was found in either CSF or brain. It must be noted that a very small amount of radioactivity was used in this study in relation to that of Enesco (14): 5 (ic C"-RNA per 2-4 kg rabbit as compared to 12 ,uc C"-RNA per 20 gm. mouse.
All these studies complement each other to form a more complete picture of the metabolic fate of exogenous RNA in the body. First, the RNA is rapidly broken down to free bases and ribose, or else contributes to the free nucleotide pool. The ribose fraction is utilized in carbohydrate metabolism or is exhaled as C0 2 . The base fraction can be utilized in the de novo synthesis of both RNA and DNA. In actively dividing cells it is primarily used for DNA synthesis, while in actively metabolising cells it is used for RNA synthesis. The RNA bases which are not incorporated are excreted as allantoin and urea in the rat, or as uric acid in primates. There is no evi dence that any of the purine or pyrimidine bases of the RNA are directly incorporated into brain RNA.
In studying the effect of chronic ad ministration of RNA, Sved (29) found that significantly less C'-RNA was in corporated into tissues of mice which had received injections of 50 mg unlabelled RNA daily for five days. This was due to increased size of the precur sor pool. Sved (29) also investigated the question of whether chronic RNA in jections increase the amount of protein synthetic activity in the brain. He re ports that there was no significant dif ference in the amount of lysine-U-C" incorporation between RNA treated and control mice. Thus RNA injections do not bring about increased synthetic activity in the brain.
The accumulating data suggest that yeast RNA does not act by being direct ly incorporated into the brain or by stimulating brain synthetic activity. This evidence however, does not invalidate the hypothesis that a memory code may be carried in an encoded intracellular RNA of the brain. The criteria neces sary for accepting this hypothesis have been analyzed elsewhere (10) .
At this point we will stop to consider by what other mechanisms the RNA in jections could act to alter learning or memory processes. Sved (30) has pro posed that injected RNA alters cell per meability by means of colloidal osmotic pressure, and that this brings about dif ferential absorption of metabolites. An other mechanism, which will be pro posed here is that RNA or its breakdown products can act as a CNS stimulant. In humans, it is probable that stimulant action could be mediated by uric acid, a major breakdown product of RNA, which is regarded by some workers as an endogenous cortical stimulant.
Many reports in the literature indicate that feeding RNA capsules to normal patients substantially increases the con centration of uric acid in their blood plasma. The components of RNA which are metabolically degraded to form uric acid are the purine bases, adenine and guanine, which together comprise 21.3% of the RNA molecule. The pyrimidine bases, uracil and cytosine, are completely degraded to CO* and urea, while the remaining phosphate and ribose portions join the normal phosphate and carbohy drate pools of the body.
In normal subjects, the circulating miscible uric acid pool is about 1 gm of uric acid. In administering 10 gms of RNA to a patient, one is potentially ad ministering 21.3% uric acid precursors; thus, one is adding 2.13 gms of uric acid to the miscible pool, increasing it three fold. Oral RNA is the most effective known means of increasing plasma uric acid concentration. To quote Nugent and Tyler (24): "Daily administration of 4 gms of uric acid by mouth had little effect on the plasma uric acid concen tration or the 24-hour urine urate excre tion. The high purine diet and 4 gms per day of DNA was moderately effec tive, while 4 gms per day of RNA usual ly resulted in a striking rise in plasma uric acid concentration and in 24-hour urine uric acid excretion. The greatest increase in plasma uric acid concentra tion occurred in the subject who was given 7 gms of RNA per day for five days."
It is interesting to note in this context that the serum uric acid level may be correlated with intelligence. Stetten and Hearon (27) studied 800 army induc tees and found a low but significant cor relation between army intelligence test scores and serum uric acid concentra tion. Even more striking evidence has been presented by Dunn et al. (12) who showed that serum urate level is corre lated with intelligence and excellence of all-round performance in high school students, and is significantly higher in executives and scientists than in crafts men.
A recent study (2) indicates that high serum uric acid is correlated with drive, achievement and leadership. Further more, serum uric acid is lower than normal in mentally retarded children (16) . Uric acid is similar in chemical structure to caffeine and theophylene. It has been suggested that it, too, may act as a stimulant. The authors of the studies cited support the hypothesis that serum uric acid is an endogenous cortical sti mulant.
Results in this laboratory (22) show that 33 patients who received 8 gms of RNA tablets for one week showed an almost two-fold increase in serum uric acid level, from an average of 4.60 mg % to 8.54 mg %. It therefore appears that the action of chronic administration of RNA on senile patients could be ex plained by increased serum uric acid and a resultant increase in cortical stimula tion.
Only in primates is uric acid the end product of purine metabolism. All other mammals produce the enzyme uricase, which breaks down uric acid to urea, a more soluble molecule. In dogs and in rats, for example, the normal plasma uric acid concentration is around 1 mg %. Following an intravenous injection of 40 mg/kg uric acid, the plasma uric acid in dogs increases to 13 mg % in five min utes. It returns to a normal level within 20 minutes, indicating the rapid action of uricase (11) . On the other hand, when humans are given an intravenous injection of 20 mg/kg uric acid, it takes four days for the plasma uric acid level to return from 12 mg '% to a normal level of 4mg% (15) .
This physiological difference between species poses a problem when we come to compare the effects of RNA injec tions into humans with those into rats. When the purines of RNA are meta bolized to uric acid, this uric acid will be maintained in the body for a con siderable period of time in humans. In contrast, it will be broken down almost immediately in the rat by the enzyme uricase. Thus we cannot expect that the administration of RNA will result in an elevated uric acid level in the rat in the same way as in humans.
It is important to note at this point that not all the studies of the effect of yeast RNA on learning in rats report positive results. As mentioned earlier, yeast RNA injections were found to en hance shock motivated simple avoidance conditioning (7) , food reinforced learn ing of a T-maze (18) and to increase rate of bar pressing for water reinforce ment (28) . On the other hand, yeast RNA did not enhance learning perfor mance of a food-motivated brightness discrimination task in a Y-maze (32) and did not enhance avoidance learning of shock-motivated spatial or pattern dis crimination (8) .
In considering all these findings on the effect of yeast RNA on learning per formance in rats, we see that perfor mance is improved only in some of the test situations. The most difficult task, that of pattern discrimination was not facilitated by RNA.
RNA injections do not affect activity as measured in an activity field (8) or in an activity wheel (28, 32) . Wagner et al. (32) have shown that RNA does not affect sensitivity to electric shock. Re sults in this laboratory (8) show that RNA does not affect basal metabolism rate in rats as measured by the method of Grad (19) but does somewhat lower the heart rate. Further research on the pharmacology of RNA injections would be needed to determine its effect more precisely.
It is still possible to advance the hypo thesis that RNA injections have a limited stimulant action in rats brought about by circulating nucleotides and xanthine bases resulting from RNA breakdown. At present this hypothesis appears to be the best available to explain the results of animal experimentation.
Present research in the RNA and memory area has concentrated almost exclusively on the supposed transfer of information from one rat to another via extracts of brain RNA (1). This is an entirely separate question from the one analyzed above concerning the mode of action of yeast RNA. Since attempts in this laboratory (9) as well as in others (20, 23) to replicate these experiments have failed, and since other workers have suggested that protein may be the trans mitting substance (26, 31) , more infor mation is needed before these data can be thoroughly discussed and evaluated. No evidence for protein-mediated trans fer has yet been observed in this labora tory (9) . It would appear from the above dis cussion that LP. injected rat brain RNA as well as yeast RNA would be broken down before it could reach the brain. Since the supposed code would be car ried in the sequence of bases, and since this sequence would be destroyed by enzymatic degradation, it is difficult to postulate how coded information would reach the brain.
Decisive evidence on this point has been provided by who demonstrated that radioactive rat brain RNA is broken down and excreted in the same manner as radioactive yeast RNA. None of the P 3a -RNA extracted from donor rat brains could be found in the brains of recipient rats following LP. injection.
The hypothesis that RNA may en code memory information is not chal lenged by the experimental evidence cited in this paper. While this theory may appear unlikely to biologists and biochemists acquainted with the well-known functions of RNA in cellular metabolism and protein synthesis in all cell types, it will doubtless serve as a framework for further important experi mentation toward the understanding of brain function in biochemical terms.
Summary
Studies on the beneficial effects of yeast RNA treatment on learning and memory in senile patients and in animal experimentation are reviewed in this paper. Experimental evidence is cited showing that yeast RNA is not incor porated into brain tissue and does not increase brain synthetic activity. Thus the therapeutic effects of RNA treat ment cannot be explained in direct rela tion to the hypothesis that RNA within the brain encodes memory information. Evidence for stimulant action of RNA, mediated by uric acid, its primary meta bolite, is presented as the basis for an alternative theory which would explain RNA action in pharmacological terms..
